Caught in the middle again: Professional ethical considerations in genetic testing for health risks

Genetic Testing

Volumn 1, Issue 3, 1998, Pages 189-200

  Juengst, Eric T ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL APPROACH; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GENETICS; GENETICS AND REPRODUCTION; GENOTYPE; HUMAN; MALE; MEDICAL ETHICS; MUTATION; PREDICTION AND FORECASTING; REVIEW; RISK FACTOR;

ANALYTICAL APPROACH; GENETICS AND REPRODUCTION;

ETHICS, MEDICAL; FAMILY; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MUTATION; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0031292157     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.189     Document Type: Article

References (91)

1. ALLEN, G.E. (1989). Eugenics and American social history, 1880-1950. Genome 31:885-889.
2. ANDREWS, L., FULLARTON, J., HOLTZMAN, N., and MOTULSKY, A. (eds.). (1994). Assessing genetic risks: Implications for health and social policy. Washington, DC: National Academy Press.
3. ANNAS, G. (1994). Rules for 'gene banks': Protecting privacy in the genetics age. In Murphy T, Lappe, M. (ed.), Justice and the human genome project. Berkeley, University of California Press. pp. 75-91.
4. ANNAS, G., GLANTZ, L., and ROCHE, P.A. (1995). Drafting the Genetic Privacy Act: Science, policy and practical considerations. J. Law Med. Ethics 23:360-367.
5. AMERICAN SOCIETY OF HUMAN GENETICS. (1994). Statement of the American Society of Human Genetics on Genetic Testing for Breast and Ovarian Cancer Predisposition. Am. J. Hum. Genet. 55:i-iv.
6. APPELBAUM, P.S., LIDZ, C., and MEISEL, A. (1987). Informed consent: Legal theory and clinical practice. New York, Oxford Univ. Press.
7. AUSTIN, H.A., and KAISER, M. (1993). Summary report to the Human Subjects Research Advisory Committee on the Meetings of the Intramural Working Group on Human Genetics Research (unpublished report, Bethesda, MD, NIH, August 23, 1993).
8. BIESECKER, B.B., BOEHNKE, M., CALZONE, K., MARKEL, D.S., GARBER, J.C., COLLINS, F.S., and WEBER, B.L. (1993). Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1974.
9. BLITZER, M.G., and MCDOWELL, G.A. (1992). Tay-Sachs disease as a model for screening in-born errors. Clin. Lab. Med. 12:463-480.
10. BLOCH, M., and HAYDEN, M.R. (1990). Predictive testing for Huntington disease in childhood: Challenges and implications. Am. J. Hum. Genet. 46:1-4.
11. BOTKIN, J.R. (1990). Prenatal screening: Professional standards and the limits of parental choice. Obstr. Gynecol. 75:875-880.
12. BRANDT, J., QUAID, K.A., FOLSTEIN, S.E., GARBER, P., MAESTRI, N.E., ABBOTT, M.H., (1989). Presymptomatic diagnosis of delayed onset diseases with linked DNA markers: The experience of HD. JAMA 261:3108-3114.
13. BRETT, A.S., and MCCULLOUGH, L.B. (1986). When patients request specific interventions: Defining the limits of the physician's obligation. NEJM 315:1347-1351.
14. BROCK, D. (1992). The human genome project and human identity. Houston Law Rev. 29:19-21.
15. CAMBIEN, F., POIRER, O., LECEF, L., EVANS, A., CAMBOUS, J., ARVIELLER, D., LUC, G., and BARD, J.M. (1992). Deletion polymorphism in the gene for angiotensin converting enzyme a potent risk factor for myocardial infarction. Nature 359:5641-5644.
16. CAPRON, A.M., LAPPE, M., CAPLAN, A., and POWLEDGE, T. (eds.) (1979). Genetic counseling: Facts, values and norms. New York, Alan R. Liss.
17. CAO, A., ROSATELLI, M.C., and GALANELLO, R. (1991). Population-based genetic screening. Curr. Opin. Genet. Dev. 1:48-53.
18. CASKEY, T.C. (1993a). Presymptomatic diagnosis: A first step toward genetic health care. Science 260:48-49.
19. CASKEY, T.C. (1993b). Molecular medicine: A spin-off from the helix. JAMA 269:1986-1992.
20. CHADWICK, R., LEVITT, M., and SCHICKLE, D. (1997). The right to know and the right not to know. Brookfield, NY, Avebury Press.
21. CHLAPOWSKI, F.S. (1991). The constitutional protection of informational privacy. Boston Univ. Law Rev. 71:133-160.
22. COLLINS, F., and the National Advisory Council on Human Genome Research (1994). Statement on the use of DNA testing for presymptomatic identification of cancer risk. JAMA 271:785.
23. COMPTON, J.G., DIGIOVANNA, J.J., SANTUCCI, S.K., KEARNS, K.S., AMOS, C., ABANGAN, D.L., et al. (1992). Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12Q. Nature Genetics 1:301-305.
24. COWAN, R. (1992). Genetic technology and reproductive choice: An ethics of autonomy. In: Kevles, D., Hood, L. (eds.) The code of codes. Cambridge, MA, Harvard University Press, pp. 244-263.
25. CROYLE, R., SMITH, K., BOTKIN, J., BATY, B., and NASH, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol. 169:63-72.
26. DAVIGNON, J., GREGG, R.E., and SING, C.F. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
27. DRAPER, E. (1991). Risky business: Genetic testing and exclusionary practices in the hazardous workplace. New York, NY: Cambridge Univ. Press.
28. EARLY, C.L., and STRONG, L.C. (1995). Certificates of confidentiality: A valuable tool for protecting genetic data. Am. J. Hum. Genet. 57:727-731.
29. FOX-KELLER, E. (1991). Genetics, reductionism and normative uses of biological information S. Cal. Law Rev. 65:285-291.
30. FRANKEL, M., and TEICH, A. (1993). Ethical and legal issues in pedigree studies. Washington, DC: AAAS.
31. GARBER, J.E., and DILLER, L. (1994). Screening children at genetic risk of cancer. Curr. Opin. Pediatr. 5:712-715.
32. GELLER, L.N., ALPER, J.S., BILINGS, P.R., BARASH, C.L., BECKWITH, J., and NATOWICZ, M. (1996). Individual, family and societal dimensions of genetic discrimination: A case study analysis. Sci. Eng. Ethics 2:71-88.
33. GELLER, G., BOTKIN, J., GREEN, M., PRESS, N., BEISECKER, B., WILFOND, B., GRANA, G., DALY, M., SCHNIEDER, K., and KAHN, M. (1997). Genetic testing for susceptibility to adult-onset cancer: The process and content of informed consent. JAMA 277:1467-1474.
34. GLASS, K., WEIJER, C., PALMOUR, R., SHAPIRO, S., LEMMENS, T., and LEBACQZ, K. (1996). Structuring the review of human genetics protocols: Gene localization and identification studies. IRB: A Review of Human Subjects Research 18(4):1-9.
35. GRAY, B. (1980). Changing federal regulations of IRBs. IRB: A Review of Human Subjects Research 2:1-5.
36. GREEN, M., and SOLNIT, A.J. (1964). Reactions to the threatened loss of a child: A vulnerable child syndrome. Pediatrics 34:56-77.
37. HARPER, P. and CLARKE, A. (1990). Should we test children for "adult" genetic disease? Lancet 335:1205-1206.
38. HEALY, B. (1997). BRCA genes - Bookmaking, Fortune-telling and Medical Care. NEJM 336:1448-1449.
39. HOFFMAN, D.E., and WULFSBERG, E.A. (1995). Testing children for gene predispositions: Is it in their best interests? J. Law, Med. Health Care 23:331-345.
40. HOLTZMAN, N. (189). Proceed with caution: Predicting genetic risks in the recombinant DNA era. Baltimore, MD: Johns Hopkins University Press.
41. HOLTZMAN, N., and WATSON, M. (1997). Promoting safe and effective genetic testing in the United States: Report of the NIH-DOE Task Force on Genetic Testing. Bethesda, MD: NIH, Sept., 1997.
42. HOLTZMAN, N. (1970). Dietary treatment of inborn errors of metabolism. Ann. Rev. Med. 21:115-132.
43. HUBBARD, R. (1986). Eugenics and prenatal testing. Intl. J. Health Services 16:227-242.
44. HUDSON, K., ROTHENBERG, K., ANDREWS, L., KAHN, M., and COLLINS, F. (1995). Genetic discrimination and health insurance: An urgent need for reform. Science 270:391-393.
45. HUGGINS, M., BLOCH, M., and KANANI, S. et al. (1990). Ethical and legal dilemmas arising during predictive testing for adult-onset disease: The experience of Huntington disease. Am. J. Hum. Gen. 47:4-12.
46. HUNTINGTON'S DISEASE SOCIETY OF AMERICA. (1989). Guidelines for predictive testing for Huntington's disease. New York, Huntington's Disease Society of American, Inc.
47. JUENGST, E.G. (1996). Respecting human subjects in genome research: A preliminary policy agenda. In H. Vanderpool (ed.) The ethics of research involving human subjects: Facing the 21st Century. Frederick, MD, University Publishing Group, pp. 401-431.
48. JUENGST, E.T. (1995). Prevention and the goals of genetic medicine. Hum. Gene Therapy 6:1595-1605.
49. KASS, N.E. (1992). Insurance for the insurers: The use of genetic tests. Hastings Center Report 229:6-11.
50. KENEN, R.H., and SCHMIDT, R.M. (1978). Stigmatization of carrier status: Social implications of heterozygote genetic screening programs. Am. J. Pub. Health 49:116-120.
51. KING, M.C., ROWELL, S. and LOVE, S.M. (1993). Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975-1980.
52. KODISH, E., MURRAY, T., and SHURIN, S. (1994). Cancer risk research: What should we tell subjects. Clin. Res. 42:396-402.
53. KOSUNEN, O., TALASNIEMI, S., and LEHTOVIRTA, M. et al. (1995). Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 26:743-748.
54. LAPHAM, E.V., KOZMA, C., and WEISS, J. (1996). Genetic discrimination: Perspectives of Consumers. Science 274:621-624.
55. LENNOX, A., KARLINSKY, H., MESCHINO, W., BUCHANAN, J., PERCY, M.E., and BERG, J.M. (1994). Molecular genetic predictive testing for Alzheimer's disease: Deliberations and preliminary recommendations. Alzheimer Disease and Associated Disorders 8:126-147.
56. LI, F.P., GARBER, J., FRIEND, S., STRONG, L., PATENAUDE, A., JUENGST, E., et al. (1992). Recommendations on predictive testing for germ-line p53 mutations among cancer-prone individuals. J. Nat. Cancer Inst. 84:1156-1160.
57. MARKEL, H. (1992). The stigma of disease: Implications of genetic screening. Am. J. Med. 939:209-215.
58. MAYR, E. (1963). Animal species and evolution. Cambridge, MA, Harvard U. Press.
59. McEWAN, J., McCARTY, K., and REILLY, P.R. (1993). A survey of medical directors of life insurance companies concerning use of genetic information. Am. J. Hum. Genet. 52:33-46.
60. MACKAY, C. (1984). Ethical issues in research design and conduct: Developing a test to detect carriers of Huntington's disease. IRB: A Review of Human Subjects Research 6:1-5.
61. MEHLMAN, M., KODISH, E., WHITEHOUSE, P., ZINN, A., SOLLITTO, S., BERGER, J., CHIAO, E., DOSICK, M., and CASSIDY, S. (1996). The need for anonymous genetic counseling and testing. Am. J. Hum. Genet. 58:393-397.
62. MULLER-HILL, B. (1988). Murderous science: Elimination by scientific selection of Jews, Gypsies, and others, Germany 1933-1945. New York, Oxford University Press.
63. NATIONAL INSTITUTE ON AGING/ALZHEIMER'S ASSOCIATION WORKING GROUP. (1996). Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347:1091-1095.
64. NELKIN, D., and TANCREDI, L. (1990). Dangerous diagnostics: The social power of biological information. New York, Basic Books.
65. NELKIN, D. (1994). Promotional metaphors and their popular appeal. Public Understanding of Science 3:25-31.
66. NELKIN, D., and LINDEE, S. (1995). The DNA mystique: The gene as a cultural icon. New York, W.H. Freeman.
67. NIH CF STUDIES CONSORTIUM, June 1992 Workshop Report. Unpublished report, National Center for Human Genome Research, NIH, Bethesda, MD.
68. NIH/DOE TASK FORCE ON GENETIC INFORMATION AND INSURANCE (1992). Genetic information and health insurance. Washington, DC: U.S. Gov. Printing Office.
69. OSTER, H., ALLEN, W., CRANDALL, L.A., MOSELEY, R., DEWAR, M., NYE, D., and McCARY, S. (1993). Insurance and genetic testing: Where are we now? Am. J. Hum. Genet. 52:565-577.
70. PARKER, L., and MAJESKE, R. (1996). Standards of care and ethical concerns in genetic testing & screening. Clin. Obstetr. Gynecol. 39(4):873-884.
71. PELIAS, M.Z. (1991). Duty to disclose in medical genetics: A legal perspective. Am. J. Med. Genet. 39:347-354.
72. PORKORSKI, R. (1988). The genetic testing debate: New technologies present to challenges in risk selection. J. Insurance Med. 20:57-61.
73. PORKORSKI, R. (1997). Insurance underwriting in the genetic era. Am. J. Hum. Genet. 60:205-216.
74. POST, S. (1994). Spheres of love: Towards a new ethics of the family. Dallas, TX, Southern Methodist University Press.
75. PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND BEHAVIORAL RESEARCH. (1983). Screening and counseling for genetic conditions. Washington, DC, U.S. Gov. Printing Office, p. 55.
76. REILLY, P.R. (1991). The surgical solution: A history of involuntary sterilization in the United States. Baltimore, MD, Johns Hopkins University Press.
77. ROTHENBERG, K., and THOMSON, E.T. (1994). Women and prenatal testing: Facing the challenge of genetic technologies. Columbus, OH, Ohio State University Press.
78. ROTHENBERG, K. (1995). Genetic information and health insurance: State legislative approaches. J. Law, Med. Ethics 23:312-320.
79. ROTHSTEIN, M. (1992). Genetic discrimination in employment and the Americans With Disabilities Act. Houston Law Rev. 29:23-85.
80. ROUSSEA, F. et al. (1991). Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N. Eng. J. Med. 325:1673-1681.
81. SAXTON, M. (1988). Prenatal screening and discriminatory attitudes about disability. In Baruch, E., D'Adamo, A., Seager, J. (eds), Embryos, ethics and women's rights. New York, Hayworth Press.
82. SCHULMAN, J.D., and STERN, H.J. (1996). Genetic predisposition testing for breast cancer. Cancer J. Sci. Am. 2:244-252.
83. STOKINGER, H.D., and SCHEEL, L.D. (1973). Hypersusceptibility and genetic problems in occupational medicine: A consensus report. J. Occupational Med. 15:564-573.
84. U.S. OFFICE FOR PROTECTION FROM RESEARCH RISK (1993). Protecting human subjects: Institutional Review Board guidebook. Bethesda, MD, OPRR, pp. 5-44.
85. WACHBROIT, R. (1993). Rethinking medical confidentiality: The impact of genetics. Suffolk University Law Rev. 27:1391-1410.
86. WERTZ, D., and FLETCHER, J. (1987). Communicating genetic risks. Science, Technology and Human Values 4:60-66.
87. WERTZ, D., FANOS, J., and REILLY, P. (1994). Genetic testing for children and adolescents: Who decides? JAMA 272:875-881.
88. WIGGINS, S., WHYTE, P., HUGGINS, M., ADAMS, S., THEILMANN, J., BLOCH, M. (1992). The psychological consequences of predictive testing for Huntington's disease. N. Eng. J. Med. 327:1401-1405.
89. WINTER, P.R., WIESNER, G.L., and FINNEGAN, J. et al. (1996). Notification of a family history of breast cancer: Issues of privacy and confidentiality. Am. J. Med. Genet. 66:1-6.
90. YARBOROUGH, M., SCOTT, J., and DIXON, L. (1989). The role of beneficence in clinical genetics: Non-directive counseling reconsidered. Theoretical Med. 10:139-149.
91. YESLEY, M. (1997). Genetic privacy, discrimination and social policy: Challenges and dilemmas. Microb. Comp. Genomics 2:19-35.